| Prabhjot Bhinder, MD | |
|
7300 N Fresno St, Fresno, CA 93720-2941 | |
| (559) 448-4470 | |
| Not Available |
| Full Name | Prabhjot Bhinder |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 7300 N Fresno St, Fresno, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326437468 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A148148 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Medical Center Redding | Redding, CA | Hospital |
| St Elizabeth Community Hospital | Red bluff, CA | Hospital |
| Mercy Medical Center Of Mt Shasta | Mount shasta, CA | Hospital |
| Banner Lassen Medical Center | Susanville, CA | Hospital |
| Oroville Hospital | Oroville, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Foundation Medical Group | 0345406294 | 263 |
| Dignity Health | 2062320559 | 58 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.
Scientists from the Florida campus of The Scripps Research Institute have found how a widely known but little-studied enzyme protects brain cells in models of Parkinson's disease.
Diagnosing heart attacks will become a more precise science thanks to the first of a new series of clinical standards just issued by the National Institute of Standards and Technology (NIST). Standard Reference Material (SRM) 2921 (human cardiac troponin complex) will help manufacturers develop and calibrate assays that measure specific protein concentrations in patient blood samples to determine whether a heart attack has occurred.
Scientists at the University of Liverpool have found that high levels of a stress hormone in recovering alcoholics could increase the risk of relapse.The study showed that cortisol, a hormone produced by the adrenal gland in response to stress, is found in high levels in chronic alcoholics, as well as those recovering from the condition.
› Verified 2 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.
Scientists from the Florida campus of The Scripps Research Institute have found how a widely known but little-studied enzyme protects brain cells in models of Parkinson's disease.
Diagnosing heart attacks will become a more precise science thanks to the first of a new series of clinical standards just issued by the National Institute of Standards and Technology (NIST). Standard Reference Material (SRM) 2921 (human cardiac troponin complex) will help manufacturers develop and calibrate assays that measure specific protein concentrations in patient blood samples to determine whether a heart attack has occurred.
Scientists at the University of Liverpool have found that high levels of a stress hormone in recovering alcoholics could increase the risk of relapse.The study showed that cortisol, a hormone produced by the adrenal gland in response to stress, is found in high levels in chronic alcoholics, as well as those recovering from the condition.
› Verified 2 days ago
| Entity Name | The Oncology Institute Ca, A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275651515 PECOS PAC ID: 5698872398 Enrollment ID: O20070514000607 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.
Scientists from the Florida campus of The Scripps Research Institute have found how a widely known but little-studied enzyme protects brain cells in models of Parkinson's disease.
Diagnosing heart attacks will become a more precise science thanks to the first of a new series of clinical standards just issued by the National Institute of Standards and Technology (NIST). Standard Reference Material (SRM) 2921 (human cardiac troponin complex) will help manufacturers develop and calibrate assays that measure specific protein concentrations in patient blood samples to determine whether a heart attack has occurred.
Scientists at the University of Liverpool have found that high levels of a stress hormone in recovering alcoholics could increase the risk of relapse.The study showed that cortisol, a hormone produced by the adrenal gland in response to stress, is found in high levels in chronic alcoholics, as well as those recovering from the condition.
› Verified 2 days ago
| Entity Name | Dignity Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336588870 PECOS PAC ID: 2062320559 Enrollment ID: O20081223000427 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.
Scientists from the Florida campus of The Scripps Research Institute have found how a widely known but little-studied enzyme protects brain cells in models of Parkinson's disease.
Diagnosing heart attacks will become a more precise science thanks to the first of a new series of clinical standards just issued by the National Institute of Standards and Technology (NIST). Standard Reference Material (SRM) 2921 (human cardiac troponin complex) will help manufacturers develop and calibrate assays that measure specific protein concentrations in patient blood samples to determine whether a heart attack has occurred.
Scientists at the University of Liverpool have found that high levels of a stress hormone in recovering alcoholics could increase the risk of relapse.The study showed that cortisol, a hormone produced by the adrenal gland in response to stress, is found in high levels in chronic alcoholics, as well as those recovering from the condition.
› Verified 2 days ago
| Entity Name | Community Foundation Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811258510 PECOS PAC ID: 0345406294 Enrollment ID: O20120723000387 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.
Scientists from the Florida campus of The Scripps Research Institute have found how a widely known but little-studied enzyme protects brain cells in models of Parkinson's disease.
Diagnosing heart attacks will become a more precise science thanks to the first of a new series of clinical standards just issued by the National Institute of Standards and Technology (NIST). Standard Reference Material (SRM) 2921 (human cardiac troponin complex) will help manufacturers develop and calibrate assays that measure specific protein concentrations in patient blood samples to determine whether a heart attack has occurred.
Scientists at the University of Liverpool have found that high levels of a stress hormone in recovering alcoholics could increase the risk of relapse.The study showed that cortisol, a hormone produced by the adrenal gland in response to stress, is found in high levels in chronic alcoholics, as well as those recovering from the condition.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prabhjot Bhinder, MD 7300 N Fresno St, Fresno, CA 93720-2941 Ph: (209) 448-4470 | Prabhjot Bhinder, MD 7300 N Fresno St, Fresno, CA 93720-2941 Ph: (559) 448-4470 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.
Scientists from the Florida campus of The Scripps Research Institute have found how a widely known but little-studied enzyme protects brain cells in models of Parkinson's disease.
Diagnosing heart attacks will become a more precise science thanks to the first of a new series of clinical standards just issued by the National Institute of Standards and Technology (NIST). Standard Reference Material (SRM) 2921 (human cardiac troponin complex) will help manufacturers develop and calibrate assays that measure specific protein concentrations in patient blood samples to determine whether a heart attack has occurred.
Scientists at the University of Liverpool have found that high levels of a stress hormone in recovering alcoholics could increase the risk of relapse.The study showed that cortisol, a hormone produced by the adrenal gland in response to stress, is found in high levels in chronic alcoholics, as well as those recovering from the condition.
› Verified 2 days ago
Maulik Shah, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7300 N Fresno St, Fresno, CA 93720 Phone: 559-448-4555 | |
Rami Alrezk, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 155 N Fresno St, Fresno, CA 93701 Phone: 559-499-6479 | |
Dr. John R Nelson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7061 N Whitney, Suite 101, Fresno, CA 93720 Phone: 559-299-0224 Fax: 559-299-4201 | |
Dexter T Estrada, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7130 N Millbrook Ave Ste 100, Fresno, CA 93720 Phone: 559-326-1222 Fax: 559-326-1230 | |
Dr. Sherry Lopez, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3209 W Shaw Ave, Suite 114, Fresno, CA 93711 Phone: 559-224-4977 Fax: 559-224-4980 | |
Maria Flordeliz Arambulo, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6484 Fax: 559-499-6501 | |
Shreela Mishra, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7085 N Chestnut Ave Ste 101, Fresno, CA 93720 Phone: 559-323-9236 Fax: 559-323-0294 |